NR1H4 and metabolic dysfunction-associated steatotic liver disease: The potential targets for treating NAFLD include lipid metabolism regulation, such as regulating fatty acid oxidation, cholesterol metabolism, and fat synthesis through FXR, AMPK, PPARs, and SREBPs (6).